EBI3 and hepatitis B virus infection: Due to lack of commercial antibody to IL-35 several years ago, previous study showed the increase in both mRNA and protein level of EBI3 in patients with hepatitis B associated liver cirrhosis, which indicated the involvement of IL-35 in the pathogenesis of HBV related liver diseases (Shi M. et al., 2015).